“…In fact, CK2 has been shown to be a prominent nuclear kinase (Krek et al, 1992) (for review, see Yu et al, 2001) and to interact with the bZIP domains of several transcription factors (Yamaguchi et al, 1998). CK2-mediated phosphorylation has also been shown to modulate the degradation (either enhancing or decreasing it) of many proteins, including IkB (Schwarz et al, 1996), PTEN (Torres and Pulido, 2001), lens connexin (Yin et al, 2000), chromatin-associated protein HMG1 (Wisniewski et al, 1999), and several transcription factors such as HMGB (Stemmer et al, 2002), Myf-5 (Winter et al, 1997), and c-Myc (Channavajhala and Seldin, 2002). CK2 is most abundant in brain (Alcazar et al, 1988;Girault et al, 1990), and its activity has been implicated in many aspects of brain function, including neuronal survival (Boehning et al, 2003), differentiation (Nuthall et al, 2004), ion channel function (Jones and Yakel, 2003;Bildl et al, 2004), and long-term potentiation and neuronal plasticity (Diaz-Nido et al, 1992;Lieberman and Mody, 1999;Reikhardt et al, 2003).…”